Peter George Lutz

Mr. Peter George Lutz is a Chairman at Crown Commercial Service, a Chairman at Enigma Holdings Group Ltd., a Chairman at Marco Polo Events Ltd., a Chairman at Mitre Group Ltd., a Chairman at Wichtig International Ltd. and an Owner at Xpg Ltd. He is on the Board of Directors at Wichtig Publishing SRL, Osler Diagnostics Ltd. and Rentplus-UK Ltd. Mr. George Lutz was previously employed as a Chairman by Oxford Quantum Circuits Ltd., an Independent Non-Executive Director by DRI Healthcare Plc, a Non-Executive Chairman by Benchmark Holdings Plc, an Advisor by Oxford Science Enterprises PLC, a Senior Independent Non-Executive Director by Ergomed Plc, a Non-Executive Director by Clinigen Group Plc, a Chief Executive Officer by Penn Pharmaceutical Services Ltd., an Executive Vice President-Europe & Asia Pacific by Wolters Kluwer Health, Inc., a Chief Operating Officer by Unilabs Clinical Trials International Ltd., a Non-Executive Chairman by Benchmark Holdings Plc, and a Head-Clinical Pathology by National Health Services, Inc. He also served on the board at Clinigen Clinical Trials Ltd., Clinigen CTS Ltd., Clinigen GAP Ltd., Clinigen Healthcare Ltd., Clinigen Pharma Ltd., Iovance Biotherapeutics UK SP Ltd., Keats Healthcare Ltd. and Pharmapatents Global Ltd. He received his undergraduate degree from The University of Manchester, a graduate degree from Northwestern University, a graduate degree from The University of Nottingham and an MBA from Kellogg School of Management.